At a glance
ClinicalIndex Comparison RecordN/ACompleted· 132 enrolled
Drug / intervention
CESM +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
In Brief
A clinical study evaluating CESM and MRI for Breast Cancer. Completed, enrolled 132 participants across 1 site.
Detailed Summary
This research study is evaluating whether contrast enhanced mammography can be used as an alternative to breast Magnetic Resonance Imaging (MRI) for cancer screening
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsGE Healthcare, Dana-Farber Cancer Institute
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 2018
Enrollment StartMay 2018
Primary CompletionAug 2023
TodayJul 2026
First PostedMar 29, 2018
Enrollment StartMay 17, 2018
Primary CompletionAug 30, 2023
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 8.3 years ago
Interventions
CESMdevice
Contrast enhanced mammography is a new type of mammogram. It uses contrast material combined with the mammogram to highlight areas that might be breast cancer and that could be missed on the mammogram alone
MRIdevice
MRI uses magnets to create a detailed image of the tissues and bones inside of the body